Li, W., & Wang, Y. The potential biomarker value of soluble CD36 in the treatment of diabetic kidney disease: Evidence from GLP-1 and insulin interventions. Frontiers Media S.A.
Chicago Style (17th ed.) CitationLi, Wenxuan, and Yangang Wang. The Potential Biomarker Value of Soluble CD36 in the Treatment of Diabetic Kidney Disease: Evidence from GLP-1 and Insulin Interventions. Frontiers Media S.A.
MLA (9th ed.) CitationLi, Wenxuan, and Yangang Wang. The Potential Biomarker Value of Soluble CD36 in the Treatment of Diabetic Kidney Disease: Evidence from GLP-1 and Insulin Interventions. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.